Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution

被引:6
|
作者
Fernandez-Munoz, Hermogenes [1 ,2 ]
Castilla-Llorente, Cristina [1 ,3 ]
Plaza, Eva M. [1 ]
Martinez-Millan, Cristina [1 ]
Heras, Inmaculada [1 ]
Iniesta, Pastora [1 ]
Amigo, Maria L. [1 ]
Ferrer-Marin, Francisca [1 ]
Candela, Maria J. [1 ]
Lozano, Maria L. [1 ]
Vicente, Vicente [1 ]
Rivera, Jose [1 ]
机构
[1] Univ Murcia, Morales Meseguer Univ Hosp, Reg Blood Donat Ctr, Haematol & Med Oncol Serv,IMIB Arrixaca,CIBERER, Murcia, Spain
[2] Rafael Mendez Univ Hosp, Haematol & Blood Therapy Serv, Lorca, Spain
[3] Gustave Roussy Inst, Haematol Serv, Villejuif, France
关键词
washed platelet concentrates; washed platelet function; washed platelet transfusion; VerifyNow (R) system; IN-VITRO QUALITY; WASHING PLATELETS; STORAGE; SYSTEM; REFRACTORINESS; APHERESIS; REMOVAL;
D O I
10.2450/2017.0277-16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Transfusion of washed platelet concentrates (W-PC) is recommended for some patients, such as those who have had previous severe allergic transfusion reactions. However, we still lack a standardised method for preparing these products. Here, we assessed the effect of a manual washing procedure on in vitro platelet quality and on the transfusion efficacy of W-PCs. Materials and methods. Buffy coat-derived W-PC in Composol solution were prepared by one-step centrifugation. Platelet activation and function were evaluated before and after washing by means of: (i) CD62 expression by flow cytometry; (ii) platelet aggregation (LTA); and (iii) the VerifyNow (R) P2Y12 test. A pilot prospective transfusion study was carried out in 11 onco-hematology patients receiving, in a short time, two consecutive transfusions: one with standard PC (S-PC) and one with W-PC. The post-transfusion platelet increment, the 1 h and 24 h corrected count increment (CCI) and occurrence of bleeding events were used as indices of transfusion efficacy. Results. Platelet recovery in W-PC was 84.8 +/- 5.4%. Washing slightly increased platelet activation in W-PC vs pre-washed samples (% CD62+ platelets 23.6 +/- 7 vs 14.8 +/- 1; p=0.03). As compared to prewash samples, platelet reactivity of W-PC as measured by VerifyNow (R) P2Y12 was significantly lower with ADP (PRU 32.2 +/- 37.7 vs 4.2 +/- 2.4, p=0.027), but similar using TRAP. Platelet aggregation responses to TRAP, collagen, ristocetin and arachidonic acid were maintained in W-PC. The pilot transfusion trial showed similar 1 h (13.5 +/- 5.6 vs 11.5 +/- 7.3, p=0.49) and 24 h (11 +/- 7.2 vs 9 +/- 6.5, p=0.48) CCI for S-PC and W-PC. Transfusion of W-PC was not associated with an increased number of bleeding events. Discussion. We have set up a simple method to obtain buffy-coat-derived W-PC, which has minor effects on in vitro platelet quality and transfusion effectiveness. This procedure can be easily implemented in transfusion centres for on-demand preparation of washed platelets.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [1] Therapeutic Effect of Apheresis and Buffy Coat-Derived Platelet Concentrates
    Zimmermann, Robert
    [J]. CLINICAL LABORATORY, 2024, 70 (08) : 1431 - 1433
  • [2] Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates
    Dijkstra-Tiekstra, Margriet J.
    Kuipers, Willeke
    Setroikromo, Airies C.
    de Wildt-Eggen, Janny
    [J]. TRANSFUSION, 2008, 48 (10) : 2114 - 2121
  • [3] Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution
    Johnson, L. N.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Marks, D. C.
    [J]. CRYOBIOLOGY, 2011, 62 (02) : 100 - 106
  • [4] Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems
    Dijkstra-Tiekstra, Margriet J.
    Kuipers, Willeke
    Setroikromo, Airies C.
    DeWildt-Eggen, Janny
    [J]. TRANSFUSION, 2008, 48 (04) : 723 - 730
  • [5] Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution
    Slichter, Sherrill J.
    Bolgiano, Doug
    Corson, Jill
    Jones, Mary Kay
    Christoffel, Todd
    Bailey, S. Lawrence
    Pellham, Esther
    [J]. TRANSFUSION, 2014, 54 (09) : 2283 - 2291
  • [6] Comparison of Therapeutic Effect of Apheresis Platelets and Buffy Coat-Derived Platelet Concentrates
    Wang, Zhaolong
    Chen, Xiaoling
    Zhang, Yangmin
    Lu, Hairong
    Ren, Lifen
    [J]. CLINICAL LABORATORY, 2024, 70 (08) : 1452 - 1456
  • [7] Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates
    Mohr, H
    Bayer, A
    Gravemann, U
    Müller, TH
    [J]. TRANSFUSION, 2006, 46 (06) : 949 - 955
  • [8] Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis
    Vasconcelos, E
    Figueiredo, AC
    Seghatchian, J
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2003, 29 (01) : 13 - 16
  • [9] Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide
    Hornsey, Valerie S.
    McMillan, Loraine
    Morrison, Alex
    Drummond, Olive
    MacGregor, Ian R.
    Prowse, Chris V.
    [J]. TRANSFUSION, 2008, 48 (12) : 2508 - 2514
  • [10] The level of cytokine mRNA in buffy coat-derived platelet concentrates is not dependent on leukocyte filtration
    Grunnet, N
    Christensen, LL
    Rndiger, N
    [J]. TRANSFUSION, 1997, 37 (09) : S417 - S417